Abstract:Diabetic cardiomyopathy was the most dangerous diabetic complication facing diabetics, with its exact mechanisms remaining obscure. Our study was conducted to investigate the expression of thrombospondin-1 (TSP-1) and neuropeptide Y (NPY) in myocardium of streptozotocin (STZ)-induced diabetic rats. We employed streptozotocin (STZ)-induced diabetic rats to study the alteration of the TSP-1 and NPY expression in the left ventricle myocardium in diabetic and normal group by immunohistochemistry and immunofluorescence. The data of weight, blood sugar and urine sugar indicated no significant difference between the two groups before the animal model was induced. Four weeks after the induction of diabetes the weight of the diabeteic animals was 189.1±18.4 g, plasma glucose was 23.7±3.25 mmol/L and urine glucose was (++) to (+++); whereas the weight of the control animals was 260.5±32.1 g, plasma glucose was 4.9±0.5 mmol/L and urine glucose undetectable (−). The differences between the control and the diabetes group were distinct. A significant increase of the TSP-1 and NPY expression was also observed in the diabetic rat's heart. The number of the NPY positive myocardium and the light density of the positive myocardium in the left ventricle of the diabetic model were 17.3±2.1 and 102.5±9.3/mm2, respectively, which were considered as increased when compared with the control that were 10.1±2.6 and 61.2±6.7, respectively. Our results support the view that high glucose conditions can induce an increased synthesis of TSP-1 through the PKC–TGF-β–TSP-1 pathway, which in turn facilitate TGF-β activation. Additionally, the activation of PKC may further lead to the over-expression of NPY. This may be involved in diabetic cardiomyopathy.

Studies on somatostatin mRNA expression in frontal cortex of diabetic rats model]

Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

[Somatostatin Mrna Expression in Hippocampus of Diabetic Rats Model].

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats.

Expression Changes of Growth-Associated Protein-43 (Gap-43) and Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and in Hippocampus of Streptozotocin-Induced Diabetic Cognitive Impairment Rats

Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats.

Studies on Changes of Brain Energy Metabolism in Diabetic Rats by 31 P Magnetic Resonance Spectroscopy

Changes of TGF - β1 , Vimentin and Desmin Gene Expression in the Renal Cortex of Streptozotocin - induced Diabetic Rats

Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin.

Decreased Thrombospondin-I (TSP-I) Expression in the Hippocampus of Streptozotocin-Induced Diabetic Rats.

Ganoderma Lucidum Polysaccharides Exert Anti-Hyperglycemic Effect On Streptozotocin-Induced Diabetic Rats Through Affecting Beta-Cells

Change of hippocampal synaptophysin in rats after intracerebroventricular streptozotocin treated rates

Changes in Myelinated Fibers in the Hippocampus of Streptozotocin-Induced Diabetic Rats: a Stereological Investigation.

Effect of streptozocin-induced diabetes mellitus on expression of methionine sulfoxide reductases and accumulation of their substrates in mouse lenses.

Morphological changes in diabetic rat’s retina induced by streptozotocin

Changes of apoptosis and its related protein expressions of hippocampal neurons in male rats with diabetes mellitus

Effect of microinjection of somatostatin into the vagal dorsal motor nerve nucleus on the actvity of intrapancreatic neurons

Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes

Complications of Rats in Diabetes Mellitus

Expression changes of methionine sulfoxide reductase B 1 in the kidneys of instreptozocin-induced diabetic mice and its relationship with oxidative stress